Game-Changing Treatment Approved: Xpovio Set to Revolutionize Multiple Myeloma Care in South Korea!
Antengene Corporation Limited (Antengene), a prominent global biopharmaceutical company, has announced a significant milestone: South Korea’s National Health Insurance Service […]